Home Newsfeeds Oppenheimer Downgrades Edwards Lifesciences to Perform

Oppenheimer Downgrades Edwards Lifesciences to Perform

Oppenheimer analyst Suraj Kalia downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Perform.

byBenzinga Newsdesk

October 28, 2022

1 minute read

Oppenheimer analyst Suraj Kalia downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Perform.

Legal
News

‘Nokia Says Draft EU Patent Rules One-Sided, Will Undermine Europe’ – Reuters News

By Happy Mohamed

April 25, 11:43 AM

https://financialpost.com/pmn/business-pmn/nokia-says-draft-eu-patent-rules-one-sided-will-undermine-europe#:~:text=BRUSSELS%20%E2%80%94%20EU%20draft%20rules%20aimed,in%20such%20areas%2C%20Nokia%20said.

NOK

US Senate Passes $858B In Annual Defense Spending, Higher Than Proposed By President Biden

By Vandana Singh

December 16, 8:12 AM

The U.S. Senate passed legislation authorizing a massive $858 billion annual defense spending, which is $45 billion more than U.S. president Joe Biden proposed. It includes $10 billion in security aid for Taiwan and $800 million for Ukraine.